Japan - Regulatory Filing Requirements and Compliance Processes for Life Sciences PART I

Instructor: Robert J Russell
Product ID: 701258
Training Level: Advanced
  • Duration: 90 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

This Regulatory compliance training is designed to provide an overview of the regulatory environment in Japan.

This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in Japan. The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in Japan. Content will also include descriptions of the methods by which regulators in the corresponding agencies process filings and registrations and what is expected in the authorization and dossier maintenance of licensed products.

The current regulatory climate will be discussed in depth and several examples will be provided to illustrate effective compliance procedures and techniques. Common issues which have caused difficulties for Life Sciences firms will also be discussed. Course content will also explain how Japan interacts with and utilizes ICH standards and how they relate with other national regulatory agencies. The course will also discuss how personnel can best address the conflicts that sometimes arise and the approach that can best be taken for resolution.

Areas Covered in the seminar:

  • Japan's Regulatory Structure for the Life Science Product Industries.
    • Demographic.
    • Regulatory Framework: ?Key Agencies Involved / Reporting Structure.
    • MHLW (Ministry of Health, Labour and Welfare).
    • PMDA (Pharmaceutical and Medical Device Agency).
    • PAFSC (Pharmaceutical Affairs and Food Sanitation Council).
    • Patents.
  • Beginning Your Company Involvement in Japan.
    • Local Office and Personnel Requirements.
    • Language Requirements.
    • License Types.
    • Overseas Manufacturers.
  • Objectives of the Rules Governing Medicinal Procedures.
  • Market Authorization Holder Overview.
    • Life Science Regulations and the Regulatory Processes in Japan.
    • Pre-Clinical.
    • Conducting Clinical Trials.
    • New Product Registrations & Filings.
    • Adverse Drug Reactions.
    • Post-Marketing Requirements.
    • Reimbursement, Audits.
    • Risk Management.
  • Japan's Use of ICH Standards / Principles
    • GCP
    • GMP
    • Quality Documents and Standards.
    • CTD / e-CTD Submissions.

Who will benefit:

This course will also be useful for sales or general management personnel who need an overview of the Regulatory Compliance requirements within Japan and how best to consider the country into one’s Business Strategy.

  • Regulatory personnel whose responsibilities require knowledge of Japan’s regulatory environment.
  • Administrative staff responsible for ensuring compliance with regulatory filings and overall regulatory compliance requirements will also find this training highly relevant.
  • Any sales or general management employee requiring an understanding of how regulations and compliance issues impact the organization will also benefit.

Instructor Profile:

Robert J. Russell, For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed